ArticleDrugs in context2018

Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries.

Daniela Opris-Belinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.